Asset profile
pemetrexed · Alimta
Small molecule
Approvedregulatory verdict
Evidence outlook
Approved: Non-Small Cell Lung Cancer
Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.
track record: Partial signal
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. Pick an indication; Research unlocks the trials, endpoints, key results and grades.
Competitive landscape
60 competitors in this universe: 0 direct rivals (same mechanism and indication), 0 same-class, 60 same-indication.
Unlock with Research ↗
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials |
|---|---|---|---|---|---|
| Pemetrexed (Alimta): this drug | Approved | Small molecule | Thymidylate synthase (TS), dihydrofolate reductase (DHFR), GARFT, Thymidylate synthase (TS) | ||
| Afatinib (Gilotrif) | Approved | Small molecule | EGFR/HER1, HER2, HER4 | ||
| Alectinib (Alecensa) | Approved | Small molecule | ALK | ||
| Alymsys (bevacizumab-Maly) | Approved | Monoclonal antibody | VEGF-A | ||
| Amivantamab | Approved | Multispecific antibody | EGFR x c-MET | ||
| Atezolizumab | Approved | Monoclonal antibody | PD-L1 | ||
| BAT1706 (Avzivi) | Approved | Monoclonal antibody | VEGF-A | ||
| BAY2927088 (Hyrnuo) | Approved | Small molecule | HER2 (ERBB2) exon 20 insertions and point mutations; also mutant-selective EGFR | ||
| Bevacizumab | Approved | Monoclonal antibody | VEGF-A, Vascular Endothelial Growth Factor Inhibitor | ||
| Bevacizumab-Awwb (MVASI) | Approved | Monoclonal antibody | VEGF-A | ||
| Binimetinib | Approved | Small molecule | MEK1/2 | ||
| Brigatinib | Approved | Small molecule | ALK | ||
| Capmatinib | Approved | Small molecule | MET | ||
| Cemiplimab | Approved | Monoclonal antibody | PD-1 | ||
| Ceritinib | Approved | Small molecule | ALK | ||
| Crizotinib | Approved | Small molecule | ALK, ROS1, MET/HGFR, and RON |
…and 45 more. Research shows the complete landscape.
Research
Unlock with Research ↗Unlock the full comparison
Research adds each competitor's evidence grade and sourced trial results, aligned per race, so you can see who actually has the data.
Upcoming events
(187 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
2026 (25)
October 2026 (4)
Phase 1Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2026-10-09 · NCT06447662 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2026-10-23 · NCT06008093 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2026-10-31 · NCT06594874 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2026-10-31 · NCT06333951 · CT.gov ↗
What to watch
November 2026 (3)
Phase 3Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2026-11 · NCT06704620 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-11-30 · NCT07122687 · CT.gov ↗
What to watch
Phase 2Chordomas, ChordomaRecruiting
Est. primary completion 2026-11-30 · NCT06794645 · CT.gov ↗
What to watch
December 2026 (18)
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-12 · NCT06943820 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2026-12 · NCT06246110 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Carcinoma of Lung, TNM Stage 4Active not recruiting
Est. primary completion 2026-12 · NCT03786692 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2026-12 · NCT06890182 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-12 · NCT05456256 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-12 · NCT06754644 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-12 · NCT04585490 · CT.gov ↗
What to watch
Phase 1/2Leptomeningeal Metastasis, Pemetrexed, PD-1 Inhibitor, CTLA4, Solid TumorsActive not recruiting
Est. primary completion 2026-12-01 · NCT06809530 · CT.gov ↗
What to watch
Phase 1Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C MutationActive not recruiting
Est. primary completion 2026-12-17 · NCT04185883 · CT.gov ↗
What to watch
Phase 2Advanced Solid TumourRecruiting
Est. primary completion 2026-12-24 · NCT06783647 · CT.gov ↗
What to watch
Phase 2DLBCLActive not recruiting
Est. primary completion 2026-12-28 · NCT05253118 · CT.gov ↗
What to watch
Phase 1Advanced Solid Tumor CancerRecruiting
Est. primary completion 2026-12-30 · NCT07381829 · CT.gov ↗
What to watch
Phase 1Locally Advanced Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8, Stage IIB Lung Cancer AJCC v8 …Recruiting
Est. primary completion 2026-12-31 · NCT05136846 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2026-12-31 · NCT02609776 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-12-31 · NCT06440954 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-12-31 · NCT04136535 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-12-31 · NCT05805631 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2026-12-31 · NCT05059522 · CT.gov ↗
What to watch
2027 (64)
January 2027 (5)
Phase 1/2Advanced Solid TumorsRecruiting
Est. primary completion 2027-01 · NCT06741644 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-01-01 · NCT06971406 · CT.gov ↗
What to watch
Phase 1/2Leptomeningeal MetastasesRecruiting
Est. primary completion 2027-01-15 · NCT06462092 · CT.gov ↗
What to watch
Phase 2Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation …Active not recruiting
Est. primary completion 2027-01-31 · NCT03744793 · CT.gov ↗
What to watch
Phase 3Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma …Recruiting
Est. primary completion 2027-01-31 · NCT04267848 · CT.gov ↗
What to watch
February 2027 (5)
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-02 · NCT06463665 · CT.gov ↗
What to watch
Phase 1Mesotheliomas PleuralRecruiting
Est. primary completion 2027-02-01 · NCT03760575 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-02-05 · NCT06946797 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-02-12 · NCT04077463 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-02-25 · NCT06897046 · CT.gov ↗
What to watch
March 2027 (2)
April 2027 (4)
Phase 1/2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-04 · NCT04956640 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-04-27 · NCT06364917 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-04-30 · NCT06944470 · CT.gov ↗
What to watch
May 2027 (5)
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-05 · NCT06969612 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-05 · NCT04410796 · CT.gov ↗
What to watch
Phase 2Head and Neck Cancer, Lung CancerRecruiting
Est. primary completion 2027-05-01 · NCT05358548 · CT.gov ↗
What to watch
Phase 4Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-05-01 · NCT07092202 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-05-05 · NCT04380636 · CT.gov ↗
What to watch
June 2027 (10)
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-06 · NCT06162221 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-06 · NCT07070440 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-06 · NCT06475300 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-06 · NCT06514027 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-06 · NCT06726265 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-06-30 · NCT04686305 · CT.gov ↗
What to watch
Phase 2Lung Adenocarcinoma, Lung Large Cell Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8Active not recruiting
Est. primary completion 2027-06-30 · NCT05198830 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-06-30 · NCT07845916 · CT.gov ↗
What to watch
Phase 2/3Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-06-30 · NCT03178552 · CT.gov ↗
What to watch
Phase 3NeoplasmsActive not recruiting
Est. primary completion 2027-06-30 · NCT05112965 · CT.gov ↗
What to watch
July 2027 (3)
Phase 2MesotheliomaActive not recruiting
Est. primary completion 2027-07 · NCT00715611 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-07-30 · NCT06448754 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-07-31 · NCT06784791 · CT.gov ↗
What to watch
August 2027 (5)
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-08 · NCT06917079 · CT.gov ↗
What to watch
Phase 2Peritoneal Malignant MesotheliomaRecruiting
Est. primary completion 2027-08-01 · NCT05001880 · CT.gov ↗
What to watch
Phase 2Lung Cancer, Non-squamous, Non-small CellRecruiting
Est. primary completion 2027-08-12 · NCT07486817 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-08-17 · NCT05498428 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-08-31 · NCT05487391 · CT.gov ↗
What to watch
September 2027 (5)
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-09-01 · NCT04253964 · CT.gov ↗
What to watch
Phase 1Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 …Active not recruiting
Est. primary completion 2027-09-23 · NCT04837716 · CT.gov ↗
What to watch
Phase 1Advanced MalignanciesActive not recruiting
Est. primary completion 2027-09-30 · NCT03233139 · CT.gov ↗
What to watch
Phase 2Urothelial Carcinoma, Metastatic CancerActive not recruiting
Est. primary completion 2027-09-30 · NCT05335941 · CT.gov ↗
What to watch
Phase 3Lung Non-Squamous Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8Active not recruiting
Est. primary completion 2027-09-30 · NCT03793179 · CT.gov ↗
What to watch
October 2027 (7)
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-10 · NCT06561685 · CT.gov ↗
What to watch
Phase 1/2Malignant Pleural MesotheliomaRecruiting
Est. primary completion 2027-10 · NCT05765084 · CT.gov ↗
What to watch
Early phase / not applicableNon-Small Cell Lung CancerRecruiting
Est. primary completion 2027-10-01 · NCT06484491 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-10-15 · NCT05012254 · CT.gov ↗
What to watch
Phase 2Lung CancerActive not recruiting
Est. primary completion 2027-10-20 · NCT05118854 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-10-31 · NCT07309952 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-10-31 · NCT07154368 · CT.gov ↗
What to watch
November 2027 (7)
Phase 1Malignant Pleural MesotheliomaActive not recruiting
Est. primary completion 2027-11 · NCT04162015 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-11 · NCT06772623 · CT.gov ↗
What to watch
Phase 2Leptomeningeal MetastasisRecruiting
Est. primary completion 2027-11 · NCT06901817 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-11 · NCT06119581 · CT.gov ↗
What to watch
Phase 2Sarcoma,Soft TissueRecruiting
Est. primary completion 2027-11-01 · NCT04605770 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-11-30 · NCT04297605 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-11-30 · NCT06142617 · CT.gov ↗
What to watch
December 2027 (6)
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-12 · NCT05431270 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-12 · NCT07846358 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-12-01 · NCT06672068 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-12-30 · NCT06663306 · CT.gov ↗
What to watch
Phase 1Malignant TumorsRecruiting
Est. primary completion 2027-12-31 · NCT07004244 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2027-12-31 · NCT06969027 · CT.gov ↗
What to watch
2028 (36)
January 2028 (1)
Phase 2Adenocarcinoma of Lung, Lung CancerRecruiting
Est. primary completion 2028-01 · NCT04105270 · CT.gov ↗
What to watch
February 2028 (3)
Phase 2Primary Central Nervous System Lymphoma, Secondary Central Nervous System Lymphoma, Relapsed Cancer, Refractory CancerRecruiting
Est. primary completion 2028-02 · NCT05681195 · CT.gov ↗
What to watch
Phase 2Solid TumorsRecruiting
Est. primary completion 2028-02-16 · NCT07415031 · CT.gov ↗
What to watch
Phase 4Advanced Solid TumorsNot yet recruiting
Est. primary completion 2028-02-29 · NCT06824792 · CT.gov ↗
What to watch
March 2028 (2)
April 2028 (4)
Phase 1/2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-04 · NCT07551778 · CT.gov ↗
What to watch
Phase 2Leptomeningeal MetastasisNot yet recruiting
Est. primary completion 2028-04-01 · NCT06441045 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-04-10 · NCT07383116 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-04-30 · NCT06839105 · CT.gov ↗
What to watch
May 2028 (6)
Phase 1Advanced Solid TumorRecruiting
Est. primary completion 2028-05 · NCT07128303 · CT.gov ↗
What to watch
Phase 2Leptomeningeal MetastasesNot yet recruiting
Est. primary completion 2028-05 · NCT06861218 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2028-05 · NCT06268210 · CT.gov ↗
What to watch
Phase 2Pleural MesotheliomasRecruiting
Est. primary completion 2028-05 · NCT07234058 · CT.gov ↗
What to watch
Phase 1/2Leptomeningeal Metastasis From Lung CancerRecruiting
Est. primary completion 2028-05-28 · NCT07744529 · CT.gov ↗
What to watch
Phase 1/2MesotheliomaRecruiting
Est. primary completion 2028-05-31 · NCT05932199 · CT.gov ↗
What to watch
June 2028 (1)
Phase 3Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2028-06 · NCT05502237 · CT.gov ↗
What to watch
July 2028 (2)
August 2028 (3)
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-08-01 · NCT05800587 · CT.gov ↗
What to watch
Phase 1/2Advanced Solid TumorNot yet recruiting
Est. primary completion 2028-08-12 · NCT07157956 · CT.gov ↗
What to watch
Phase 2Solid TumorsRecruiting
Est. primary completion 2028-08-15 · NCT07492680 · CT.gov ↗
What to watch
September 2028 (3)
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-09 · NCT07020065 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-09-15 · NCT07680764 · CT.gov ↗
What to watch
Phase 2Malignant Peritoneal Mesothelioma, Peritoneal Mesothelioma, Mesothelioma, Mesothelioma, Malignant, Malignant MesotheliomaRecruiting
Est. primary completion 2028-09-21 · NCT06057935 · CT.gov ↗
What to watch
October 2028 (3)
Phase 2/3Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-10 · NCT06335355 · CT.gov ↗
What to watch
Phase 2MedulloblastomaActive not recruiting
Est. primary completion 2028-10-13 · NCT01878617 · CT.gov ↗
What to watch
Phase 2/3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-10-31 · NCT07131319 · CT.gov ↗
What to watch
November 2028 (3)
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-11 · NCT07181499 · CT.gov ↗
What to watch
Phase 3Unresectable Pleural MesotheliomaActive not recruiting
Est. primary completion 2028-11-16 · NCT06097728 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2028-11-30 · NCT01993810 · CT.gov ↗
What to watch
December 2028 (5)
Phase 1Ewing Sarcoma, Colorectal AdenocarcinomaRecruiting
Est. primary completion 2028-12 · NCT03715933 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2028-12 · NCT07020221 · CT.gov ↗
What to watch
Phase 1Solid TumorRecruiting
Est. primary completion 2028-12-31 · NCT05382559 · CT.gov ↗
What to watch
Phase 2Lung Adenocarcinoma MetastaticRecruiting
Est. primary completion 2028-12-31 · NCT07624487 · CT.gov ↗
What to watch
Phase 3Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8 …Active not recruiting
Est. primary completion 2028-12-31 · NCT04092283 · CT.gov ↗
What to watch
2029 (30)
January 2029 (4)
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-01 · NCT05098132 · CT.gov ↗
What to watch
Phase 2/3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-01 · NCT06712316 · CT.gov ↗
What to watch
Phase 3Metastatic Non-squamous Lung CancerRecruiting
Est. primary completion 2029-01 · NCT05692999 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-01-31 · NCT06706076 · CT.gov ↗
What to watch
February 2029 (3)
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-02-23 · NCT06996782 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2029-02-28 · NCT07472647 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2029-02-28 · NCT05984277 · CT.gov ↗
What to watch
March 2029 (3)
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-03 · NCT06970639 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2029-03-06 · NCT07661173 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-03-31 · NCT07098988 · CT.gov ↗
What to watch
April 2029 (4)
Phase 1Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2029-04 · NCT07699757 · CT.gov ↗
What to watch
Phase 1Large B-cell Lymphoma, Central Nervous System LymphomaNot yet recruiting
Est. primary completion 2029-04 · NCT07608731 · CT.gov ↗
What to watch
Phase 2MesotheliomaNot yet recruiting
Est. primary completion 2029-04 · NCT07514793 · CT.gov ↗
What to watch
Phase 3Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8Active not recruiting
Est. primary completion 2029-04-30 · NCT06632327 · CT.gov ↗
What to watch
May 2029 (5)
Phase 1Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-05 · NCT06835569 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-05 · NCT07397338 · CT.gov ↗
What to watch
Early phase / not applicableNon-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2029-05 · NCT07538193 · CT.gov ↗
What to watch
Phase 2Metastatic Bladder Urothelial Carcinoma, Metastatic Malignant Solid Neoplasm, Stage IV Bladder Cancer AJCC v8, MTAP DeletionRecruiting
Est. primary completion 2029-05-10 · NCT06630416 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-05-23 · NCT06667076 · CT.gov ↗
What to watch
June 2029 (2)
August 2029 (1)
September 2029 (3)
Phase 2Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2029-09 · NCT05633667 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-09-07 · NCT06875310 · CT.gov ↗
What to watch
Phase 2Stage III Lung Cancer AJCC v8, Stage III Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Cancer AJCC v8 …Recruiting
Est. primary completion 2029-09-30 · NCT04892953 · CT.gov ↗
What to watch
October 2029 (1)
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2029-10 · NCT07777822 · CT.gov ↗
What to watch
November 2029 (2)
2030 (18)
January 2030 (4)
Phase 1Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2030-01 · NCT06607185 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2030-01 · NCT06745882 · CT.gov ↗
What to watch
Phase 2/3Non-Small Cell Lung CancerActive not recruiting
Est. primary completion 2030-01-16 · NCT05800015 · CT.gov ↗
What to watch
Phase 2/3Double BlindRecruiting
Est. primary completion 2030-01-24 · NCT07662395 · CT.gov ↗
What to watch
February 2030 (1)
Phase 1Advanced Solid TumorsRecruiting
Est. primary completion 2030-02-25 · NCT05067283 · CT.gov ↗
What to watch
April 2030 (1)
Phase 1Advanced Solid TumorsRecruiting
Est. primary completion 2030-04-30 · NCT05719558 · CT.gov ↗
What to watch
May 2030 (3)
Phase 4Non-Small Cell Lung CancerRecruiting
Est. primary completion 2030-05-18 · NCT07279935 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2030-05-28 · NCT05061550 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2030-05-31 · NCT07822542 · CT.gov ↗
What to watch
June 2030 (1)
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2030-06-30 · NCT07775040 · CT.gov ↗
What to watch
July 2030 (3)
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2030-07-30 · NCT06561386 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2030-07-31 · NCT07739966 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2030-07-31 · NCT07709585 · CT.gov ↗
What to watch
September 2030 (1)
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2030-09 · NCT07822984 · CT.gov ↗
What to watch
November 2030 (2)
December 2030 (2)
Phase 1/2Metastatic Biliary Tract Carcinoma, Metastatic Colon Carcinoma, Metastatic Esophageal Carcinoma …Recruiting
Est. primary completion 2030-12-09 · NCT07594626 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2030-12-31 · NCT07050043 · CT.gov ↗
What to watch
2031 (6)
January 2031 (1)
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2031-01-31 · NCT07507188 · CT.gov ↗
What to watch
April 2031 (1)
Phase 3Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2031-04 · NCT07829549 · CT.gov ↗
What to watch
August 2031 (1)
Phase 2/3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2031-08-12 · NCT07063745 · CT.gov ↗
What to watch
October 2031 (2)
Phase 2/3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2031-10 · NCT06236438 · CT.gov ↗
What to watch
Phase 3Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8Recruiting
Est. primary completion 2031-10-15 · NCT05624996 · CT.gov ↗
What to watch
December 2031 (1)
Phase 2/3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2031-12 · NCT07005102 · CT.gov ↗
What to watch
2032 (4)
January 2032 (2)
2033 (2)
2035 (1)
December 2035 (1)
Phase 2/3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2035-12-31 · NCT07365319 · CT.gov ↗
What to watch
2039 (1)
April 2039 (1)
Phase 3Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8Recruiting
Est. primary completion 2039-04-01 · NCT06096844 · CT.gov ↗
What to watch
All registered studies
Every ClinicalTrials.gov study of this drug's own program, grouped by indication and phase. Research unlocks the studies themselves: titles, statuses, dates and featured-trial cross-links.